Portal de recerca
ESTUDIO DE FASE 2, ALEATORIZADO, DE BÚSQUEDA DE DOSIS PARA EVALUAR LA SEGURIDAD Y LA ACTIVIDAD ANTICITOMEGALOVIRUS (CMV) DE MARIBAVIR FRENTE A VALGANCICLOVIR PARA EL TRATAMIENTO DE INFECCIONES POR CMV EN RECEPTORES DE TRASPLANTES SIN ENFERMEDAD ORGÁNICA P OR CMV.
Dades bàsiques
- Protocol:
- 1263-203
- EURDRACT:
- 2010-024247-32
- NCT:
- Centre:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Any inici:
- 2013
- Any de finalització:
- 2014
Objectius del projecte
Observaciones: Estado Comité: FINALIZADO
Documents
- No hi ha documents
Participants
Grups d'Investigació
Finançadors - Promotors
Resultats de l'Assaig Clínic
[Hepatitis C treatment in special patient groups].
Berenguer, Marina; (...); Castellano, Gregorio
Article. 2014
ADVERSE EFFECTS OF TRIPLE THERAPY WITH BOCEPREVIR (BOC) AND TELAPREVIR (TVR) IN CLINICAL PRACTICE IN PATIENTS WITH ADVANCED HEPATIC FIBROSIS
Salmeron, J.; (...); Prieto, M.
Article. 10.1016/S0168-8278(14)61356-8. 2014
Altered underlying tubular function in HBV monoinfected patients receiving nucleos(t)ide analogs in a real-world setting: MENTE Study
Rodriguez Novoa, Sonia; (...); Castro, Angeles
Article. 2014
ANABOLIC ANDROGENIC STEROIDS (AAS) ILLICIT USE IS A RAPIDLY GROWING CAUSE OF DRUG-INDUCED LIVER INJURY (DILI): A PROSPECTIVE SERIES FROM THE SPANISH-LATIN-AMERICAN DILI REGISTRY
Medina-Caliz, I.; (...); Andrade, R. J.
Article. 10.1016/S0168-8278(14)60472-4. 2014
Analisis de las causas de suspension de tratamiento con triple terapia antiviral en pacientes con hepatitis C.
Ruiz Ramos J; (...); Poveda Andrés JL
Abstract of Published Item. 10.7399/fh.2014.38.3.1171. 2014
Anidulafungin-Induced Alopecia
Ruiz-Ramos J; (...); Poveda-Andrés JL
Article. 10.1177/1060028014524534. 2014
Are abdominal obesity and body mass index independent predictors of hemorheological parameters?
Letter. 10.3233/CH-121656. 2014
Avances en el tratamiento de la hepatitis C.
Vinaixa C, Aguilera V, Berenguer M
Abstract of Published Item. 10.1016/j.medcli.2013.01.041. 2013
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis
Lorente Fernández L; (...); Casanova-Estruch B
Article. 10.1016/j.nrl.2013.06.014. 2014
Comparison of results of combined liver-kidney transplantation vs. isolated liver transplantation.
Aguilera V; (...); Mir J
Article. 10.1016/S1665-2681(19)31366-3. 2013
Control of Diabetes Mellitus in Liver Transplant Recipients
Ramos-Prol, Agustin; (...); Francisco Merino-Torres, Juan
Article. 2014
Chronic kidney disease after liver transplantation: pretransplantation risk factors and predictors during follow-up.
Giusto M; (...); Merli M
Article. 10.1097/TP.0b013e3182884890. 2013
Drug Interaction Between Oral Cyclosporine Modified and Iron
Domingo-Chiva, E; (...); Poveda-Andres, JL
Article. 10.1177/1060028013514734. 2014
EBV-associated post-transplant lymphoproliferative disorder after umbilical cord blood transplantation in adults with hematological diseases
Article. 10.1038/bmt.2013.190. 2014
EFFECT OF CYP3A5 GENOTYPE ON TACROLIMUS DOSE REQUIREMENT, NEPHROTOXICITY AND ACUTE REJECTION IN KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES
Rojas, L.; (...); Alino, S. F.
Article. 2013
EFFECTIVENESS OF TRIPLE THERAPY WITH BOCEPREVIR OR TELAPREVIR IN A MULTICENTRE CLINICAL PRACTICE COHORT OF HCV TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED HEPATIC FIBROSIS. SVR-12W AFTER TREATMENT
FERNANDEZ, C.; (...); Salmeron, J.
Article. 10.1016/S0168-8278(14)61360-X. 2014
EFFECTS OF POLYMORPHIMS OF CYP3A5 AND ABCB1 GENES ON CHRONIC NEPHROPATHY: COHORT STUDY
Rojas, L.; (...); Alino, S. F.
Article. 2013
Epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole for six Candida species as determined by the colorimetric Sensititre YeastOne method.
Cantón E; (...); Suárez A
Article. 10.1128/JCM.01230-13. 2013
Estrategias para evitar la recidiva viral B despues del trasplante hepatico.
Abstract of Published Item. 10.1016/S0210-5705(14)70067-6. 2014
Estudio de utilizacion de boceprevir y telaprevir para el tratamiento de la hepatitis C cronica.
Marrero-Álvarez P; (...); Poveda-Andrés JL
Abstract of Published Item. 10.7399/FH.2014.38.1.1128. 2014
Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population
Bosó V; (...); Aliño SF
Article. 10.1097/FTD.0b013e3182a94e65. 2014
Haematological, biochemical and inflammatory parameters in inactive Behcet's disease. Its association with red blood cell distribution width
Vayá A; (...); Ricart JM
Article. 10.3233/CH-131744. 2014
Haemophagocytic syndrome in a liver transplant patient during treatment with Telaprevir.
Rodríguez-Medina B; (...); Berenguer M
Article. 10.1016/S1665-2681(19)31305-5. 2013
HCV-Induced Immune Responses Influence the Development of Operational Tolerance After Liver Transplantation in Humans
Bohne, Felix; (...); Sanchez-Fueyo, Alberto
Article. 10.1126/scitranslmed.3008793. 2014
Hepatitis B virus recurrence after liver transplantation and evolution of viral quasispecies
Buti, Maria; (...); Rodriguez-Frias, Francisco
Article. 2014
IMPACT OF ANTICOAGULANT THERAPY ON UPPER GASTROINTESTINAL BLEEDING (UGI) IN PATIENTS WITH LIVER CIRRHOSIS. RESULTS FROM A RETROSPECTIVE MULTICENTRIC CASE-CONTROL STUDY
Cerini, F.; (...); Garcia-Pagan, J. C.
Article. 10.1016/S0168-8278(14)60019-2. 2014
Improved Renal Function in Liver Transplant Recipients Treated for Hepatitis C Virus With a Sustained Virological Response and Mild Chronic Kidney Disease
Blé M; (...); Berenguer M
Article. 10.1002/lt.23756. 2014
Is erythrocyte sedimentation rate a useful inflammatory marker independently of the hematocrit? Comparison results with plasma viscosity
Letter. 10.3233/CH-141864. 2014
Long-term outcome of 'long-term liver transplant survivors'.
Rubín A; (...); Berenguer M
Article. 10.1111/tri.12118. 2013
Management of anemia induced by triple therapy in patients with chronic hepatitis C: challenges, opportunities and recommendations.
Romero-Gómez M; (...); Calleja JL
Article. 10.1016/j.jhep.2013.07.014. 2013
Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation.
Rojas LE; (...); Aliño SF
Article. 10.1097/FPC.0b013e3283642fb3. 2013
PREDICTIVE FACTORS OF SURVIVAL AND PROGNOSTIC SCORE VALIDATION IN LIVER RETRANSPLANTATION FOR SEVERE HEPATITIS C RECURRENCE: THE IMPORTANCE OF HCV THERAPY BEFORE AND AFTER RETRANSPLANTATION
Song, A. T. W.; (...); Samuel, D.
Article. 10.1016/S0168-8278(13)60186-5. 2013
Progress in hepatitis C treatment
Vinaixa, Carmen, Aguilera, Victoria, Berenguer, Marina
Review. 2013
Progression of liver fibrosis in post-transplant hepatitis C: mechanisms, assessment and treatment.
Berenguer M, Schuppan D
Article. 10.1016/j.jhep.2012.12.014. 2013
Protease inhibitors impair renal function in HCV-infected immunocompetent patients
Fernandez-Carrillo, Carlos; (...); Luis Calleja, Jose
Meeting Abstract. 2014
Red blood cell distribution width is not related with inflammatory parameters in morbidly obese patients
Article. 10.1016/j.clinbiochem.2014.01.020. 2014
Reply to: "Renal impairment and anemia during triple therapy"
Romero-Gómez M; (...); Calleja JL
Letter. 10.1016/j.jhep.2014.01.007. 2014
Rheological red blood cell properties in morbidly obese and super obese patients
Letter. 10.3233/CH-141853. 2014
Selective ophthalmic intra-arterial melphalan therapy for advanced retinoblastoma: implementation and outcomes of a new chemotherapy protocol.
Valero García S; (...); Poveda Andrés JL
Article. 10.1177/1078155212457964. 2013
Sexual Dysfunction in Cirrhotic Patients Awaiting Liver Transplantation.
Rodriguez-Medina, Beatriz; (...); Berenguer, Marina
Article. 2013
Single Nucleotide Polymorphisms, SNPs, Associated With the Efficacy and Security of Immunosuppressive Treatment in Heart Transplantation
Sanchez-Lazaro, I.; (...); Salvador-Sanz, A.
Article. 10.1016/j.healun.2014.01.392. 2014
SNPs and taxane toxicity in breast cancer patients
Bosó V; (...); Aliño SF
Article. 10.2217/PGS.14.127. 2014
TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS OF A RANDOMIZED STUDY (PREBLIN STUDY)
Buti, M.; (...); Esteban, R.
Article. 10.1016/S0168-8278(14)61200-9. 2014
TENOFOVIR MONOTHERAPY VERSUS LAMIVUDINE PLUS ADEFOVIR IN LAMIVUDINE-FAILURE PATIENTS RESCUED WITH LAMIVUDINE PLUS ADEFOVIR COMBINATION: INTERIM ANALYSIS OF THE TENOSIMP-B CLINICAL TRIAL
Jorquera, F.; (...); Rodriguez, M.
Article. 10.1016/S0168-8278(14)61201-0. 2014
The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients
Roman A; (...); Ussetti P
Article. 10.1016/j.trre.2014.01.001. 2014
Tratamiento de la hepatitis C en grupos de pacientes especiales.
Berenguer M; (...); Castellano G
Abstract of Published Item. 10.1016/S0210-5705(15)30004-2. 2014
Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature
Lizan, L; (...); Polanco, C
Review. 10.2147/PPA.S67253. 2014
TREATMENT-NAIVE STABLE LIVER TRANSPLANT PATIENTS WITH GENOTYPE-1 HCV INFECTION: PHARMACOKINETIC RESULTS OF ADJUSTED DOSING WITH TACROLIMUS OR CYCLOSPORINE IN THE TELAPREVIR REPLACE STUDY
Forns, X.; (...); Bertelsen, K.
Article. 2014
Triple Therapy for HCV Cirrhosis in Liver Transplant Candidates. High Rate of Prevention of HCV Recurrence after Liver Transplantation (LT) in Well Selected Patients
Maria Braithwaite, Ana; (...); Berenguer, Marina
Article. 2014
T-tube or no T-tube in cadaveric orthotopic liver transplantation: the eternal dilemma: results of a prospective and randomized clinical trial.
López-Andújar R; (...); De Juan Burgueño M
Article. 10.1097/SLA.0b013e318286e0a0. 2013
Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury
Robles-Diaz M; (...); Safer and Faster Evidence-based Translation Consortium
Article. 10.1053/j.gastro.2014.03.050. 2014